Search Results for "Pregnancy"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pregnancy. Results 341 to 350 of 981 total matches.
Treatment of Clostridioides difficile Infection
The Medical Letter on Drugs and Therapeutics • Sep 06, 2021 (Issue 1632)
of rifaximin
could alter the INR.
PREGNANCY AND LACTATION — Use of oral
vancomycin or fidaxomicin ...
Clostridioides (formerly Clostridium) difficile infection
(CDI) is the most common infectious cause of
healthcare-associated diarrhea in adults. Guidelines
on management of CDI have recently been updated.
Antiviral Drugs for Seasonal Influenza for 2024-2025
The Medical Letter on Drugs and Therapeutics • Dec 09, 2024 (Issue 1717)
should be continued for up to 1 week after the end of
the outbreak.
PREGNANCY AND LACTATION — Pregnant ...
Influenza is generally a self-limited illness, but
pneumonia, respiratory failure, and death can occur,
especially in persons at increased risk for influenza
complications (see Table 1). Updated information on
influenza activity and antiviral resistance is available
from the CDC at cdc.gov/flu.
Med Lett Drugs Ther. 2024 Dec 9;66(1717):193-8 doi:10.58347/tml.2024.1717a | Show Introduction Hide Introduction
Comparison Table: Some Oral Antiseizure Medications (online only)
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
,
and phenobarbital can
decrease felbamate levels
No adequate pregnancy
or lactation studies in
humans; decreased ...
View the Comparison Table: Some Oral Antiseizure Medications
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e133-40 doi:10.58347/tml.2024.1708b | Show Introduction Hide Introduction
Prosthetic Heart Valves
The Medical Letter on Drugs and Therapeutics • Aug 20, 2012 (Issue 1397)
complicating a pregnancy with anticoagulation.
CONCLUSION — Bioprosthetic valves are preferred
for patients ...
Prosthetic heart valves have been used effectively in
patients with mitral and aortic valvular heart disease
for more than 50 years, but no replacement valve
developed to date is suitable for all types of patients.
In Brief: Esomeprazole Strontium
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014 (Issue 1447)
into bone. It is not recommended
for use in children or during pregnancy
because of the absence of safety ...
The FDA has approved the proton pump inhibitor (PPI) esomeprazole strontium for use in adults for the same indications as esomeprazole magnesium (Nexium): treatment of gastroesophageal reflux disease (GERD), prevention of NSAID-induced gastric ulcers, eradication of Helicobacter pylori, and treatment of pathological hypersecretory conditions. It was first marketed in December 2013 as a branded drug (Esomeprazole Strontium) and a month later as a generic drug.Strontium is incorporated into bone. It is not recommended for use in children or during pregnancy because of the absence of safety data...
In Brief: Adstiladrin – A Gene Therapy for Bladder Cancer (online only)
The Medical Letter on Drugs and Therapeutics • Mar 06, 2023 (Issue 1671)
infection in immunocompromised patients.
PREGNANCY AND LACTATION — Nadofaragene
firadenovec ...
Nadofaragene firadenovec-vncg (Adstiladrin – Ferring), an adenoviral vector-based gene therapy,
has been approved by the FDA for treatment of adults
with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer
(NMIBC) with carcinoma in situ with or without
papillary tumors. It is the first adenoviral vector-based
gene therapy to be approved in the US for
this indication. The immune checkpoint inhibitor
pembrolizumab (Keytruda) was approved for the
same indication in 2021.
Med Lett Drugs Ther. 2023 Mar 6;65(1671):e40-1 doi:10.58347/tml.2023.1671e | Show Introduction Hide Introduction
In Brief: Anktiva for Bladder Cancer (online only)
The Medical Letter on Drugs and Therapeutics • Jun 24, 2024 (Issue 1705)
hours
after receiving Anktiva and BCG.
PREGNANCY AND LACTATION — Nogapendekin alfa
inbakicept ...
Nogapendekin alfa inbakicept-pmln (Anktiva –
ImmunityBio), a first-in-class interleukin-15 (IL15)
receptor agonist, has been approved by the FDA for
use with Bacillus Calmette-Guérin (BCG) for treatment
of patients with BCG-unresponsive nonmuscle
invasive bladder cancer (NMIBC) with carcinoma in
situ with or without papillary tumors. Such patients
generally undergo bladder tumor resection, followed
by intravesical BCG treatment, but treatment failure
and cancer recurrence are common. The adenoviral
vector-based intravesical gene therapy nadofaragene
firadenovec-vncg (Adstiladrin)...
Med Lett Drugs Ther. 2024 Jun 24;66(1705):e105-6 doi:10.58347/tml.2024.1705e | Show Introduction Hide Introduction
Valproate and Other Anticonvulsants For Psychiatric Disorders
The Medical Letter on Drugs and Therapeutics • Dec 11, 2000 (Issue 1094)
IN PREGNANCY — Fetal exposure to phenytoin, carbamazepine, valproate,
phenobarbital and other older ...
Anticonvulsants are now widely used for treatment of psychiatric illnesses, particularly bipolar disorder. Lithium is the standard drug for treatment of bipolar disorder, but it can cause severe toxicity, serum concentrations must be monitored, and it is not effective in some patients.
Rifaximin (Xifaxan) for Travelers' Diarrhea
The Medical Letter on Drugs and Therapeutics • Sep 13, 2004 (Issue 1191)
, and should not be taken during
pregnancy.
• For severe diarrhea, a fluoroquinolone is preferred.
PAGE 74 ...
Rifaximin (Xifaxan - Salix), a non-absorbed oral antibiotic derived from rifampin (Rifadin, and others), has been approved by the FDA for treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in patients 12 years of age or older. It has been available in Europe since 1987.
A New Indication for Gamma Hydroxybutyrate (Xyrem) in Narcolepsy
The Medical Letter on Drugs and Therapeutics • Jan 30, 2006 (Issue 1227)
incontinence
and sleepwalking also occurred.
GHB’s safety in pregnancy and breastfeeding are
unknown ...
Gamma hydroxybutyrate (GHB), a central-nervous-system depressant notorious for its use in "date rape", was approved by the FDA in 2002 as sodium oxybate (Xyrem - Jazz Pharmaceuticals) for oral treatment of cataplexy in patients with narcolepsy. Now it has also been approved for treatment of excessive daytime sleepiness (EDS) in these patients. Xyrem is a Schedule III controlled substance.